Skip to main content
. Author manuscript; available in PMC: 2017 Feb 24.
Published in final edited form as: Obes Rev. 2013 Jun 13;14(8):606–619. doi: 10.1111/obr.12040

Table 2.

Bradford Hill Criteria for causality applied to evidence evaluating SSB consumption and risk of Type 2 Diabetes (T2D)

Bradford Hill Criteria SSB consumption and risk of T2D
1) Strength of Association Significant positive association
RR: 1.26 (1.12, 1.41) for 1–2 servings/day
2) Consistency Consistent data from large prospective cohort studies
3) Specificity SSB has been shown to increase risk of related
metabolic conditions and unrelated conditions such as
dental caries and reductions in bone mineral density
4) Temporality Prospective studies have established temporality
5) Biological Gradient (dose-response) Increase 1 SSB/d associated with about 15%
increased risk of T2D
RR: 1.15 (1.11, 1.20)
6) Biological Plausibility Evidence regarding incomplete compensation for
liquid calories, glycemic effects of consuming large
amounts of rapidly absorbable sugars and metabolic
effects of fructose provide biological plausibility
7) Experimental Evidence RCTs with clinical T2D as an endpoint are
logistically difficult; however, experimental evidence
from studies of biomarkers of T2D and cardiovascular
risk provide support.

Malik VS, Hu FB. Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages. Current Diabetes Reports. 2012.